A Path to Prevention of Elder Abuse in Long-term Care. General Population Prevalence Study

NCT ID: NCT06786065

Last Updated: 2025-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

7727 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-09-30

Study Completion Date

2025-01-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this cross-sectional study is to learn about how common experiences of different forms of abuse are among people over the age of 65 years in Sweden. The main question it aims to answer is:

• What is the prevalence of abuse of older people in Sweden?

Participants are recruited through a random selection of people over 65 years from the populations register. Eligible participants are asked to answer a questionnaire including items about experiences of emotional, physical, sexual or financial abuse as well as neglect.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Detailed Description Main aim

\- Investigate the prevalence of abuse of older people in Sweden

Secondary aims:

* Investigate factors associated with reporting abusive experiences, e.g., health factors, frailty, care dependence
* Investigate resilience factors associated with abusive experiences, e.g., social support, positive emotion regulation and sense of purpose.

Study design and data collection Cross-sectional questionnaire study using a combination of digital and postal questionnaires and carried out by Statistics Sweden. A national representative sample of older adults will be used.

The invitation to participate and questionnaire will be sent to altogether 16 000 older adults (≥ 65 years) selected from the population register at random. To be able to provide information about experiences of abuse among both men and women, in all age groups and among the most vulnerable population, older adults residing in care facilities, the sample is stratified according to the information given in the study population description. Population weights will be used in analyses.

Material:

The questions about abusive experiences used in the study is part of the "REAGERA-S20" questionnaire developed and validated in a separate study (Clinical Trial register number NCT06659822). In addition, other relevant and validated questionnaires are included, e.g., The Tilburg Frailty Indicator, the UCLA loneliness scale, the Positive Emotional Regulation scale and a scale measuring sense of purpose.

In addition, statistics from Swedish registers concerning e.g., usage of home care services, sociodemographic factors and indicators of health status will be used to explore factors associated with elder abuse on different levels of the socio-ecological framework.

Analysis:

Prevalence will be reported for the different types of abuse (emotional, physical, sexual, financial abuse and neglect) in different relational contexts (partner, child, staff, other known perpetrator, unknown perpetrator).

Regression analyses will be used to investigate associations between reporting different forms of abuse and factors on different levels of the socio-ecological model. On an individual and relational level characteristic of respondents, e.g., age, educational level, own previous victimization, resilience factors as well as frailty and different health indicators from registers will be considered. On the community and societal level factors such as living conditions will be considered.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Elder Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention (observational study)

No intervention (observational study)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 65 or older (born in 1959 or earlier)

Exclusion Criteria

* None
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Region Östergötland

OTHER

Sponsor Role collaborator

City of Gothenburg

UNKNOWN

Sponsor Role collaborator

Karolinska Institutet

OTHER

Sponsor Role collaborator

Norwegian University of Science and Technology

OTHER

Sponsor Role collaborator

Linkoeping University

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Johanna Simmons

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Johanna Simm, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Linkoeping University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Linkoeping University

Linköping, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A Path to Prevention of Elder

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

2023-07931-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.